# FDA Inspection 1287054 - Apozeal Pharmaceuticals Inc. - October 15, 2025

Source: https://www.keypedia.com/records/fda_inspections/apozeal-pharmaceuticals-inc/5cedf772-ff92-416e-9e31-51a75fbf805a
Source feed: FDA_Inspections

> FDA Inspection 1287054 for Apozeal Pharmaceuticals Inc. on October 15, 2025. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1287054
- Company Name: Apozeal Pharmaceuticals Inc.
- Inspection Date: 2025-10-15
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Philadelphia District Office

## Related Documents

- [FDA Inspection 1161191 - 2021-12-15](https://www.keypedia.com/records/fda_inspections/apozeal-pharmaceuticals-inc/555e223a-c978-4fad-ae2a-963c346e2f3c)
- [FDA Inspection 1085686 - 2019-04-09](https://www.keypedia.com/records/fda_inspections/apozeal-pharmaceuticals-inc/a1f553bf-210b-4f01-81a3-d4276c44e2b1)
- [FDA Inspection 1073461 - 2018-11-09](https://www.keypedia.com/records/fda_inspections/apozeal-pharmaceuticals-inc/7cc4ed28-5119-46be-a4a6-c61fea01ef07)
- [FDA Inspection 1026757 - 2017-04-05](https://www.keypedia.com/records/fda_inspections/apozeal-pharmaceuticals-inc/0742599d-5476-42fb-b682-442d63f24132)
- [FDA Inspection 807963 - 2012-11-21](https://www.keypedia.com/records/fda_inspections/apozeal-pharmaceuticals-inc/f38fef44-9ff8-4979-85c9-22b6a14f1cdf)

Company: https://www.keypedia.com/companies/apozeal-pharmaceuticals-inc/0eae3e34-426a-4c5f-a067-d762962ea916

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8